Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omecamtiv mecarbil PK in stable heart failure
NCT01077167Phase 2Withdrawn
- Sponsor
- Cytokinetics
- Start
- Jul 2010
- Primary completion
- May 2011
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of omecamtiv mecarbil in heart failure (HF), sponsored by Cytokinetics. Planned start Jul 2010; status: withdrawn.
02
Drugs
omecamtiv mecarbil
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01077167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01077167.